Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD for Tremor in Parkinson's Disease
NCT02818777Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Oct 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Cannabidiol with Placebo (2 arms). Primary endpoints: Severity of Participants Reporting Study-related Adverse Events at Each Dose Level, Number of Participants Had Changes in Orthostatic Blood Pressure at 5 weeks and 17 more. Started Oct 2016; status: completed.
02
Drugs
cannabidiol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02818777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02818777.